March 7, 2021
Business News

Gilead announces another cancer deal – MarketWatch

Shares of Gilead Sciences Inc.
gained 0.3% in premarket trading on Tuesday after the drugmaker on Monday evening announced a deal worth more than $6 billion with Tango Therapeutics. The collaboration, which began in 2018, has been expanded to allow Gilead option rights to 15 programs rather than the original five. Gilead will give Tango a $150 million upfront payment and make a $20 million investment. It can also option each of the programs for up to $410 million per program. …

Click here to view the original article.

Related Posts

You might also like ...

FD7 Ventures Invests in BitcoinBlack, Canada’s First Bitcoin Credit Card
Article feature image
China Exports Soar To Highest Level In Decades After COVID-19 Hit – NDTV
AON Splash Image
High-Quality Healthcare, Education Systems Highlighted in China’s Two Sessions